Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-in-duced mouse model of Parkinson's disease

doi:10.1016/j.intimp.2024.112715

科研成果详情

题名	Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-in-duced mouse model of Parkinson's disease
作者	Ovlyakulov, Begench 1,2,3,4,5; Hu, Bei-Lei3,4,5; Kan, Hong-Yang3,4,5; Guo, Qing1,2; Li, Xiao-Fen1,2; Fan, Hui-Hui1,2; Wu, Hong-Mei1,2; Wang, Jian-Yong3,4,5; Zhang, Xiong3,4,5; Zhu, Jian-Hong1,2,3,4,5
发表日期	2024-09-30
发表期刊	International Immunopharmacology 影响因子和分区
语种	英语
原始文献类型	Article
关键词	Parkinson's disease Escitalopram Citalopram Neuroinflammation Neuroprotection
其他关键词	ANTIDEPRESSANTS ; TOLERABILITY ; PAROXETINE ; EFFICACY ; VENLAFAXINE ; DEPRESSION ; SYMPTOMS ; MEMORY ; MICE ; SSRI
摘要	Citalopram and escitalopram are structurally close-related antidepressants and both forms are widely used in the world. We aimed to comparatively evaluate the anti-neuroinflammatory and neuroprotective effects of escitalopram and citalopram in Parkinson's disease (PD) mouse model. Mice were randomly divided into six groups and received 6-hydroxydopamine (6-OHDA) or vehicle administration. The mice were then treated with escitalopram, citalopram or saline for consecutive 7 days. Behaviors, neuroinflammation, neurotransmitters, and neurotoxicity were assessed. Results showed that citalopram but not escitalopram worsened body weight loss and increased freezing time in the PD mice. Both drugs had no impact on the anxiety-like behaviors but ameliorated the depressive-like behaviors as in elevated plus maze and sucrose splash tests. Escitalopram but not citalopram ameliorated motor discoordination in the PD mice as in rotarod test. In accordance, escitalopram but not citalopram attenuated the 6-OHDA-induced nigrostriatal dopaminergic loss. Further mechanistic investigations showed that both drugs mitigated activations of microglia and astrocytes and/or levels of pro-inflammatory cytokines in the PD mice, but escitalopram showed appreciably better effects in the substantia nigra. Neurotransmitter examination in the prefrontal cortex suggested that the two drugs had comparable effects on the disturbed neurotransmitters in the PD mice, but citalopram was prone to disrupt certain normal homeostasis. In conclusion, escitalopram is moderately superior than citalopram to suppress neuroinflammation and to protect against dopaminergic neuronal death and motor discoordination in the 6-OHDA-induced PD mice. Our findings imply that escitalopram shall be prescribed with priority over citalopram to treat PD patients with depression as escitalopram may meanwhile provide greater additional benefits to the patients.
资助项目	Zhejiang Pro-vincial Natural Science Foundation [LD19H090001]; National Nat-ural Science Foundation of China [82071585, 82271282]
出版者	ELSEVIER
ISSN	1567-5769
EISSN	1878-1705
卷号	139
DOI	10.1016/j.intimp.2024.112715
页数	12
WOS类目	Immunology ; Pharmacology & Pharmacy
WOS研究方向	Immunology ; Pharmacology & Pharmacy
WOS记录号	WOS:001275765400001
收录类别	SCIE ; SCOPUS ; PUBMED
URL	查看原文
PubMed ID	39032471
SCOPUSEID	2-s2.0-85198994907
通讯作者地址	[Zhang, Xiong]Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou 325027, Zhejiang, Peoples R China. ; [Zhang, Xiong]Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325027, Zhejiang, Peoples R China. ; [Zhu, Jian-Hong]Wenzhou Med Univ, Biomed Res Bldg B305 B307, Wenzhou 325035, Zhejiang, Peoples R China.
Scopus学科分类	Immunology and Allergy;Immunology;Pharmacology
SCOPUS_ID	SCOPUS_ID:85198994907
TOP期刊	TOP期刊
引用统计
文献类型	期刊论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/216845
专题	公共卫生学院_预防医学系公共卫生学院附属第二医院附属第二医院_神经内科第二临床医学院、附属第二医院、育英儿童医院
通讯作者	Zhang, Xiong; Zhu, Jian-Hong
作者单位	1.Wenzhou Med Univ, Sch Publ Hlth, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; 2.Wenzhou Med Univ, Inst Nutr & Dis, Sch Publ Hlth, Wenzhou, Zhejiang, Peoples R China; 3.Wenzhou Med Univ, Affiliated Hosp 2, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; 4.Wenzhou Med Univ, Affiliated Hosp 2, Inst Geriatr Neurol, Wenzhou, Zhejiang, Peoples R China; 5.Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China
第一作者单位	公共卫生学院; 预防医学系; 附属第二医院; 第二临床医学院，附属第二医院、育英儿童医院; 神经内科
通讯作者单位	附属第二医院; 第二临床医学院，附属第二医院、育英儿童医院; 神经内科; 温州医科大学
第一作者的第一单位	公共卫生学院
推荐引用方式 GB/T 7714	Ovlyakulov, Begench,Hu, Bei-Lei,Kan, Hong-Yang,et al. Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-in-duced mouse model of Parkinson's disease[J]. International Immunopharmacology,2024,139.
APA	Ovlyakulov, Begench., Hu, Bei-Lei., Kan, Hong-Yang., Guo, Qing., Li, Xiao-Fen., ... & Zhu, Jian-Hong. (2024). Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-in-duced mouse model of Parkinson's disease. International Immunopharmacology, 139.
MLA	Ovlyakulov, Begench,et al."Escitalopram moderately outperforms citalopram towards anti-neuroinflammation and neuroprotection in 6-hydroxydopamine-in-duced mouse model of Parkinson's disease".International Immunopharmacology 139(2024).